USD 5.26
(-3.13%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -37.99 Million USD | 62.21% |
2022 | -100.52 Million USD | 41.61% |
2021 | -172.16 Million USD | -927.45% |
2020 | -16.75 Million USD | -738.69% |
2019 | -1.99 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -23.63 Million USD | 37.8% |
2024 Q2 | -5.92 Million USD | 74.94% |
2023 Q2 | -17.51 Million USD | 54.59% |
2023 Q4 | -37.99 Million USD | 13.75% |
2023 Q1 | -38.55 Million USD | 61.64% |
2023 FY | -37.99 Million USD | 62.21% |
2023 Q3 | -44.04 Million USD | -151.53% |
2022 Q2 | -124.32 Million USD | 11.02% |
2022 FY | -100.52 Million USD | 41.61% |
2022 Q4 | -100.52 Million USD | 8.7% |
2022 Q1 | -139.72 Million USD | 18.84% |
2022 Q3 | -110.1 Million USD | 11.44% |
2021 FY | -172.16 Million USD | -927.45% |
2021 Q2 | -6.21 Million USD | -1410.24% |
2021 Q3 | -183.53 Million USD | -2855.0% |
2021 Q1 | 474.03 Thousand USD | 102.83% |
2021 Q4 | -172.16 Million USD | 6.19% |
2020 FY | -16.75 Million USD | -738.69% |
2020 Q3 | -1.17 Million USD | 0.0% |
2020 Q4 | -16.75 Million USD | -1323.89% |
2020 Q2 | - USD | -100.0% |
2020 Q1 | 15.48 Million USD | 0.0% |
2019 FY | -1.99 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Abbott Laboratories | 8.97 Billion USD | 100.423% |
Allurion Technologies Inc. | 3.82 Million USD | 1094.503% |
Artivion, Inc. | 300.4 Million USD | 112.646% |
Avanos Medical, Inc. | 121.4 Million USD | 131.293% |
Butterfly Network, Inc. | -109.6 Million USD | 65.34% |
Butterfly Network, Inc. | -109.6 Million USD | 65.34% |
Bio-Rad Laboratories, Inc. | 1 Billion USD | 103.792% |
Boston Scientific Corporation | 8.62 Billion USD | 100.44% |
CONMED Corporation | 966.95 Million USD | 103.929% |
Edwards Lifesciences Corporation | -449.1 Million USD | 91.541% |
Paragon 28, Inc. | 36.39 Million USD | 204.394% |
Glaukos Corporation | 290.27 Million USD | 113.088% |
Globus Medical, Inc. | 53.11 Million USD | 171.528% |
Inspire Medical Systems, Inc. | -160.69 Million USD | 76.358% |
Integer Holdings Corporation | 1.01 Billion USD | 103.734% |
Medtronic plc | 24.76 Billion USD | 100.153% |
Myomo, Inc. | -6.27 Million USD | -505.901% |
Nevro Corp. | 117.61 Million USD | 132.302% |
Owlet, Inc. | -1.34 Million USD | -2732.963% |
Penumbra, Inc. | 66.85 Million USD | 156.823% |
Smith & Nephew plc | 2.78 Billion USD | 101.366% |
Sonendo, Inc. | 26.34 Million USD | 244.218% |
STERIS plc | 3.17 Billion USD | 101.196% |
Stryker Corporation | 10.02 Billion USD | 100.379% |
Vapotherm, Inc. | 102.66 Million USD | 137.003% |
Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 100.681% |